91Ӱ

News

This protein does “The Twist”

Luis Sandoval
By Luis Sandoval
Aug. 25, 2024

Proteins are constantly performing a kind of dance. They move and contort their bodies to fulfill specific functions inside our bodies. The NMDAR protein executes an especially hard dance routine in our brains. One wrong step can lead to a range of neurological disorders. NMDAR binds to the neurotransmitter, glutamate, and another compound, glycine. These bindings control NMDAR’s dance steps. When their routine is over, the NMDAR opens. This open ion channel generates electrical signals critical for cognitive functions like memory.

The problem is that scientists couldn’t figure out the last step in NMDAR’s routine—until now. Cold Spring Harbor Laboratory Professor and his team have deciphered the critical dance move in which NMDAR rotates into an open formation. In other words, they’ve learned the NMDAR “Twist.”

To capture this key step, Furukawa and his team used a technique called electron cryo-microscopy (cryo-EM), which freezes and visualizes proteins in action. First, the team had to find a way to keep a type of called GluN1-2B in its open pose long enough to image it. So, Furukawa teamed up with Professors Stephen Traynelis and Dennis Liotta at Emory University. Together, they discovered a molecule that favors NMDAR in an open position.

This animation takes us inside NMDAR as it dances its way into an open formation.
This animation takes us inside NMDAR as it dances its way into an open formation.

“It’s not the most stable conformation,” Furukawa explains. “There are many pieces dancing independently in NMDAR. They have to coordinate with each other. Everything has to go perfectly to open the ion channel. We need a precise amount of electrical signals at the right time for proper behaviors and cognitions.”

The cryo-EM images allow researchers to see precisely how the NMDAR’s atoms move during its “Twist.” This may one day lead to drug compounds that can teach the correct moves to NMDARs that have lost a step. Better might have applications for neurological disorders like Alzheimer’s and depression. Furukawa explains:

“Compounds bind to pockets within proteins and are imperfect, initially. This will allow us and chemists to find a way to fill those pockets more perfectly. That would improve the potency of the drug. Also, the shape of the pocket is unique. But there could be something similarly shaped in other proteins. That would cause side effects. So, specificity is key.”

Indeed, there are many types of NMDARs in the brain. Another recent study from Furukawa’s lab offers the first view of the . Surprisingly, its dance moves are completely different. This routine results in unusual patterns of electrical signals.

In other words, we’re mastering the Twist.

Enjoy reading 91ӰToday?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Luis Sandoval
Luis Sandoval

Luis Sandoval is a communications specialist at . He writes about science research, education and outreach for the .

 

Get the latest from 91ӰToday

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
News

Cracking cancer’s code through functional connections

July 2, 2025

A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.